PEPTIDE DERIVATIVES Russian patent published in 2002 - IPC

Abstract RU 2187511 C2

FIELD: organic chemistry, peptides. SUBSTANCE: invention proposes peptide derivatives of the general formula (I): P-R1-R2-R3-R4 or their pharmaceutically acceptable salts where P means an organic hydrophobic group comprising of from 5 to 20 carbon atoms of the formula RCO- where R means aryl(2-10 C)alkyl or heteroaryl(2-10 C)alkyl where aryl or heteroaryl group in R is substituted optionally with one or more (1-4 C)alkyl, halogen atom, cyano-group or (1-4 C)alkoxy-group; R1 means a sequence of 5 L-amino acid presented as AA1-AA2-AA3-AA4-AA5 and R3 means a single L-amino acid taken among Ala, Gly, azaalanine or azaglycine; or R1 means a sequence of 3 L- amino acids presented as AA6-AA7-AA8 and R3 means a sequence of 3 L-amino acids presented as AA9-AA10- -AA11 where AA1 is taken among Ala, Ile, Arg, Gap, GapMe4 and Lys(=C(NMe2)2); AA2 is taken among Ala, Lys, Ile and Arg; AA3 is taken among Ala and Asn; AA4 is taken among Ala, Asn, Lys, Arg and His; AA5 is taken among Val and Thr; AA6 is taken among Ala, Arg and Ile; AA7 is taken among Lys, Arg, Ala and Ile; AA8 means Ala; AA9 is taken among Ala and Leu; AA10 is taken among Ala and Arg; AA11 means Ala; R2 means a group of the formula (II) or formula (III) where Ra and Rb are taken independently among hydrogen atom and (1-4 C)alkyl and A means methylene; and R4 means OH, NH2 or NRcRd where Rc is taken among (1-4 C)alkyl, 3-carbamoylphenyl, 4-carbamoylphenyl, 4-(carbamoylmethyl)phenyl, 4-(carboxymethyl)-phenyl, 4-(methoxycarbonylmethyl)phenyl, 2-morpholinoethyl and a group of the formula -A1-G1 where A1 means (3 C)alkylene or A1 means a group of the formula -A2-B2- where A2 means p-phenylene and B2 means (1-4 C)alkylene; and G1 means a group of the formula -N=C[N(Rp)2]2 where each Rp means hydrogen atom; or A1 means a group of the formula -A4-B4- where A4 means p-phenylene and B4 means -CH2--CO-; and G1 means 2-morpholinoethylamino-group or 4-[2-(2-hydroxyethoxy)ethyl] -piperazine-1-yl; and Rd means hydrogen atom or (1-4 C)alkyl; or R4 means 4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl, 1-piperidyl or 4-substituted-1-piperidyl where this 4-substitute is taken among carboxy-group and carbamoyl-group. Invention proposes a method of synthesis of compounds of the formula (I) by claim 1and a pharmaceutical composition showing ability to inhibit T- cellular immune response mediated by molecule MHC of class II comprising the peptide derivative of the formula (I) or its pharmaceutically acceptable salt. Invention proposes a method of treatment of MHC- dependent of class II T-cellular mediated autoimmune or inflammatory disease. The described invention proposes peptides showing minimal losses associated with degradation in release from a medicinal preparation. EFFECT: improved method of treatment, valuable medicinal properties. 15 cl

Similar patents RU2187511C2

Title Year Author Number
UROTENSIN-II AGONISTS AND ANTAGONISTS 2001
  • Koj Dehvid Kh.
  • Rossovski Vojtsekh J.
RU2263679C2
NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS 2000
  • Sadat-Aalai Din
  • Morgan Barri A.
RU2263680C2
SYNTHETIC PEPTIDES USING IN BIOLOGICAL TESTS FOR DETECTION INFECTIONS CAUSED BY VIRUSES HIV-1 OF GROUP 0 1998
  • Shenebo Deni Mari Bernar
  • Delan'O Zhan-Fransua Juber
  • Gadell' Stefan Zhan Ksav'E
  • Rijun'E Fransua Iv
RU2184742C2
TRI-, TETRA-, PENTA- AND POLYPEPTIDES AND THEIR THERAPEUTIC USE AS ANTIDEPRESSANT AGENT 1995
  • Genri B. Abadzhian
  • Dzhon F. Nobl
  • Dzhozef Dzh. Khlavka
RU2182910C2
TREATMENT OF NEUROLOGICAL DISEASES 2017
  • Holscher, Christian
RU2755997C2
GLP-1 ANALOGUES 1999
  • Dong Zheng Ksin
  • Koj Dehvid Kh.
RU2208015C2
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS 2010
  • Yuj Chunsi
  • Syuj Lina
  • Chen Yujkhua
  • Yan Binbin
  • Tu Shitsyan
RU2627065C2
MAITANZINOID DERIVATIVES WITH SELF-SPLITTING PEPTIDE LINKERS AND THEIR CONJUGATES 2018
  • Widdison, Wayne, C.
RU2765098C2
COMPOSITIONS FOR TREATING CANCER USING ANTAGONISTS WHICH BIND TO THE PD-1 SIGNALING PATHWAY COMPONENT AND MEK INHIBITORS 2015
  • Junttila, Melissa
RU2733735C2
DERIVATIVES OF POLYPEPTIDE SHOWING INSULINOTROPIC ACTIVITY, PHARMACEUTICAL COMPOSITION, METHODS OF ENHANCEMENT OF INSULIN EFFECT, METHODS OF TREATMENT OF DIABETIC PATIENTS 1993
  • Glenn S.Ehndrjus
  • Gehston O.Domi
  • Majkl L.Franker
  • Ehrik R.Larson
RU2128663C1

RU 2 187 511 C2

Authors

Kotton Ronal'D

Ehdvards Filip Nejl

Ljuk Richard Vil'Jam Artur

Dates

2002-08-20Published

1997-02-18Filed